Business Wire

NC-DOLE-FOOD-COMPANY

21.11.2022 15:01:36 CET | Business Wire | Press release

Share
Dole Pineapples Group Receives Grand Winner Award for Social Responsibility in Costa Rica

Dole plc (NYSE: DOLE) announced today that The American-Costa Rican Chamber of Commerce (AmCham) recognized the company’s pineapple operations in Costa Rica S.A., with the Social Responsibility in Action Award in the Employees Category for their project "Information and Wellbeing Centers."

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221121005224/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Farm Managers and Employees from Dole’s Santa Fe and Muelle Farms were present at the award ceremony, along with representatives from Dole Tropical Products and Dole’s Costa Rican subsidiary. (Photo: Business Wire)

In the designation AmCham further distinguished this project as the overall Grand Winner among over 40 submittals which entered the chamber’s Corporate Social Responsibility event. This year marks the 26th anniversary of the award and the first year when a Grand Winner was selected among all proposals.

The “Information and Wellbeing Centers” is an integrated initiative that works toward positively impacting the lives of farm employees and families by providing support and access to information from over thirty public and private organizations that interact with citizens daily.

The concept was developed through a diagnosis to understand the major needs that the Dole rural workforce has and how the company could assist in better fulfilling these needs. A myriad of paperwork and processes that workers and families are confronted with—and have difficulty resolving—or result in lost opportunities, were identified. Frequently, dealing with bureaucracy also results in lost time and revenue, increased expenses, long distance travel, and diminished livelihoods, particularly in rural areas that have limited public and private services.

In practical terms, the Information Centers allow Dole workers to access services for themselves or direct family members to resolve issues linked to their social benefits, residence, personal finance and much more. Those issues would be difficult or too costly to solve by themselves.

As one Dole farmworker stated, “My spouse could not receive medical attention because she did not have a formal job and did not have the resources to make contributions to the medical plan. Thanks to the intervention of the Information Center we managed to make the registration and my spouse can enjoy social security benefits.”

Dole is the first business of any kind in the country to offer this free service to its farm employees directly at the workplace. The Information and Wellbeing Center is a resource at the hands of 3,300 workers and their families, which promotes personal and family development, a sense of belonging and motivation.

“We are extremely proud to receive two awards at this prestigious social responsibility event. The designation as Grand Winner among so many fine examples of social responsibility in Costa Rica is a testament to the team effort required to conceive and build these Centers for our farm employees,” said Mr. Renieri Nuñez, Vice President of Pineapple Operations for Latin America. “There is no doubt that when efforts are focused on the person, our major company asset, results can be amazing. This started as an idea to solve paperwork problems and has turned out to be the most significant step in motivating employees at all levels in our organization and producing tangible results in the lives of our families.”

Through direct contacts with more than 39 institutions, the centers provide training on the use of digital platforms and support for information, advice, and follow-up of personal cases and procedures with the participating organizations.

Some of the achievements are reflected in the positive impact on household finances, use of time, and in the reduction of geographic, technological, educational, economic, and social gaps. Families have greater access to citizen rights, public and private benefits, services, and opportunities. By assisting its employees with this unique service, Dole has enjoyed increased commitment, reduced absenteeism, and created a very positive workplace environment.

The project by the numbers (as of August 2022):

  • Information centers have now been extended to all four company pineapple farms.
  • 3,978 users have been served by the centers.
  • 11,552 services provided.
  • 10,195 inquiries via WhatsApp.
  • 6,378 interventions have been successful in obtaining results such as licenses, passports, national and residence cards, insurance, loans, opening of bank or savings accounts, and procedures on computer platforms, among others.
  • At least 2,170 services have contributed to address multidimensional poverty.
  • On average, 34.4% of users have used the center on more than one occasion.
  • 536 workers have been trained in the management of personal procedures.

In 2020, Dole introduced its three-pillared Sustainability Framework, The Dole Way, and its ongoing commitment For Food, For Nature and For People. Just as Dole Costa Rica was a pioneer nearly 25 years ago in the development of global environmental management systems in agriculture to frame its efforts 'For Nature,' at the beginning of this decade the company once again innovates by establishing Information and Wellbeing Centers focused on its most important resource: 'For People.'

About Dole plc

Dole plc is one of the world’s largest producers and marketers of high-quality fresh fruit and fresh vegetables. Dole plc is an industry leader in many of the products it sells, as well as in nutrition education and research. For more information, please visit www.dole.com.

About The Dole Way

In April 2020, Dole Food Company announced The Dole Way, introducing its sustainability commitment and framework around People, Nature and Food. For more information, please visit www.dole.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221121005224/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

IEO and Laife Reply Join Forces to Digitalise the Biobank Through Artificial Intelligence10.2.2026 10:00:00 CET | Press release

The two partners launch “Bianca”, the first large-scale digitalisation initiative in Italy focused on histopathological samples, aimed at training AI algorithms to support pathologists’ diagnostic activities. The Pathology Division of the European Institute of Oncology (IEO) and Laife Reply, the Reply Group company specialised in AI and Big Data solutions for the healthcare sector, have entered into a collaboration to develop Bianca, the first project in Italy aimed at creating an AI-based digital biobank designed as an integral part of clinical diagnostic practice. The initiative is part of a broader technological innovation journey that structurally integrates research and development into routine diagnostic processes in pathology, transforming the traditional histopathological sample workflow into an end-to-end digital ecosystem. The complete digitalisation of histopathological and molecular diagnostic workflows aims to make analysis more efficient, scalable and reproducible, laying

OPEX® Corporation Introduces the Velo™ Series of Premium Desktop and High Production Document Scanners10.2.2026 10:00:00 CET | Press release

OPEX® Corporation, a global leader in Next Generation Automation providing innovative solutions for warehouse, document and mail automation, has announced the launch of its Velo™ Series powered by InoTec, a new class of premium desktop and free standing high production scanners. The OPEX Velo scanners are engineered to deliver exceptional performance, reliability and image quality and offer industry-standard TWAIN/ISIS connectivity to help simplify deployment into existing capture environments. These state-of-the-art scanners are ideal for service bureaus, government agencies, healthcare providers and enterprise capture operations. “The Velo Series powered by InoTec introduces an entirely new class of scanners to the OPEX portfolio, expanding the options available to both our current customers and organizations considering OPEX for the first time,” said Dann Worrell, President, Document and Mail Automation, OPEX. “By broadening our offerings, we can better align the right solution with

New ZOLL Zenix Monitor/Defibrillator Receives MDR Approval10.2.2026 10:00:00 CET | Press release

ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that Zenix®, the company’s most clinically advanced and easy-to-use professional monitor/defibrillator, is approved under the European Union (EU) Medical Device Regulation 2017/745, commonly referred to as EU MDR. The Zenix monitor/defibrillator is a groundbreaking device that redefines efficiency, clarity, and intelligence in both EMS and hospital settings. Built from years of feedback from customers, Zenix combines intuitive design with powerful functionality to enhance patient care and automate workflows for ease-of-use. Featuring a large, durable touchscreen, Zenix provides critical information when it’s needed. With on-the-fly customization, healthcare professionals can make real-time adjustments, helping them stay in control during high-pressure situations. Equipped with ZOLL’s innovative Real BVM Help® and exclusive Real CPR Help® technology, Zenix gives healthcare pro

Expereo Elevates expereoOne with New Digital Case Management Capabilities, Delivering Faster, Clearer and More Predictable Service Resolution10.2.2026 10:00:00 CET | Press release

Expereo is redefining what’s possible for global enterprises at CiscoLive Amsterdam with the launch of its enhanced Digital Case Management (DCM) capability in expereoOne. As the world-leading managed Network as a Service (NaaS) provider, Expereo is putting customers firmly in control - slashing resolution times, cutting through operational noise and ensuring everyone is aligned every step of the way. With DCM, service issues are no longer bottlenecks: instead, enterprises experience swift, transparent outcomes, with every stakeholder empowered through a single, real-time view of progress. DCM is designed around a simple objective: enable enterprises to resolve issues faster, with greater clarity and full control, through a fully digital, software-first workflow inside expereoOne. Customers can create, manage and track cases end-to-end within a single platform, ensuring predictable, consistent and aligned service experiences across their global network footprint. Unified, digital-first

U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Takeda’s Oveporexton (TAK-861) as a Potential First-in-Class Therapy for Narcolepsy Type 110.2.2026 09:15:00 CET | Press release

This FDA Acceptance is a Milestone for People Living with Narcolepsy Type 1 Who Need New and Different Treatment OptionsOveporexton is an Orexin Agonist Designed to Restore Orexin Signaling and Address the Underlying Orexin Deficiency that Causes Narcolepsy Type 1The Prescription Drug User Fee Act (PDUFA) Target Action Date is the Third Quarter of this Calendar Year Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) and granted Priority Review for oveporexton (TAK-861) for the treatment of narcolepsy type 1 (NT1). Oveporexton is an investigational oral orexin receptor 2 (OX2R)-selective agonist designed to address the underlying orexin deficiency that causes NT1 by restoring orexin signaling. The FDA has set a Prescription Drug User Fee Act (PDUFA) goal date in the third quarter of this calendar year. Takeda remains on track to potentially bring the first approved orexin agonist treatment to people living

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye